• Afsan Bhadelia, Liliana De Lima, Héctor Arreola-Ornelas, Kwete Xiaoxiao Jiang XJ Afsan Bhadelia, Xiaoxiao Jiang Kwete, Natalia M. Rodriguez, and Felicia Marie Knaul are with the Institute for Advanced Study of the Americas, Uni, Natalia M Rodriguez, and Felicia Marie Knaul.
• Afsan Bhadelia, Xiaoxiao Jiang Kwete, Natalia M. Rodriguez, and Felicia Marie Knaul are with the Institute for Advanced Study of the Americas, University of Miami, Miami, FL. Liliana De Lima is with the International Association for Hospice and Palliative Care, Houston, TX. Héctor Arreola-Ornelas is with Fundación Mexicana para la Salud, A.C., Mexico City, Mexico.
• Am J Public Health. 2019 Jan 1; 109 (1): 58-60.

AbstractAnnually, more than 61 million people worldwide experience about 6 billion days of serious health-related suffering that could be alleviated with access to palliative care and pain relief. However, palliative care is limited or nonexistent in most parts of the world. The access abyss is so stark that 50% of the world's poorest populations live in countries that receive only 1% of the opioid analgesics distributed worldwide. By contrast, the richest 10% of the world's population live in countries that receive nearly 90% of the opioid pain relief medications.The Lancet Commission on Global Access to Palliative Care and Pain Relief developed a framework to measure the global burden of serious health-related suffering and generated the evidence base to address this burden.We present the inequities in access to pain relief and highlight key points from country responses, drawing from and building on recommendations of the Lancet Commission report "Alleviating the Access Abyss in Palliative Care and Pain Relief-An Imperative of Universal Health Coverage" to close the access abyss in relief of pain and other types of serious health-related suffering.

14 keywords...

hide…